Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension

Status:
Active, not recruiting

Trial end date:
2026-08-01

Target enrollment:

Participant gender:

To assess the long-term safety and efficacy of the BAROSTIM NEO System in trial (NCT01471834) participants.

N/A

CVRx, Inc.